CMC aspect of Oligonucleotide Therapeutics

Aleksandra is currently Associate Principal Scientist in the Advanced Drug Delivery group at AstraZeneca, contributing to the development of clinical drug candidates in the cardio vascular therapeutic area. Aleksandra focuses on developing new approaches to formulation for RNA and oligos and she is involved in numerous academic collaborations within this area. She is an author of 25+ peer reviewed publications. Aleksandra obtained her PhD (2009) in Pharmaceutical Science from King’s College London under the guidance of Prof. Jayne Lawrence. She was awarded the prestigious CW Maplethorpe Research and Teaching Postdoctoral Fellowship from the University of London (2009-2011). Prior to joining AstraZeneca, Aleksandra was a postdoctoral fellow in the Dept. of Physical Chemistry at Lund University, Sweden. She is passionate about closing the gap between academia and industry and interested in new approaches to drug formulations that ensure the delivery of safe and efficient therapeutics to patients.